Aurora Julianna Lingg, Physician Assistant - Medical Medicare: Medicare Enrolled Practice Location: 3501 Burnett Dr, Murrysville, PA 15668 Phone: 412-804-1131 |
Elizabeth A Eisler, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 4614 William Penn Hwy, Murrysville, PA 15668 Phone: 724-733-1414 Fax: 724-327-4505 |
Chelsey Jenae Smail, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 4262 Old William Penn Hwy Ste 200, Murrysville, PA 15668 Phone: 412-668-4444 Fax: 724-468-0039 |
Cameron James Keen, PA-C Physician Assistant - Medical Medicare: Medicare Enrolled Practice Location: 4620 William Penn Hwy, Murrysville, PA 15668 Phone: 412-403-1183 |
Justine Marie Roberts, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 4057 Old William Penn Hwy, Murrysville, PA 15668 Phone: 724-216-3353 |
Mrs. Jennifer Ashley Gialloreto, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 4212 Old William Penn Hwy, Murrysville, PA 15668 Phone: 724-837-4070 Fax: 724-837-8836 |
News Archive
ViroPharma, Inc. today announced that, in connection with the completion of the acquisition of ViroPharma by Shire plc (LSE: SHP, NASDAQ: SHPG), it has commenced a tender offer (the "Convertible Notes Tender Offer") to repurchase, at the option of each holder, any and all of its outstanding 2.00% Convertible Senior Notes Due 2017 (the "Convertible Notes").
Some people find quinine to be bitter while others can drink it like water. Now, scientists from the Monell Center and collaborators report that individual differences in how people experience quinine's bitterness are related to underlying differences in their genes.The findings, published online in the journal Human Molecular Genetics, demonstrate that genetic variation in regions of DNA that encode bitter taste receptors predicts a person's perception of bitterness from quinine.
New treatments for breast cancer, skin and wound healing and obesity will be revealed at an international conference in Cairns, Australia next week.
A team of clinicians and scientists from the National Cancer Centre Singapore (NCCS), Singapore General Hospital (SGH) and A*STAR's Genome Institute of Singapore (GIS) has identified a novel method to treat triple-negative breast cancer (TNBC). They discovered that cancer cells switch between different cell states and are able to change from being less aggressive ('epithelial') to being more aggressive ('mesenchymal'), and vice versa.
› Verified 5 days ago